169167 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
Methods of developing selective peptide antagonists
#302ASSAYS FOR IDENTIFYING COMPOUNDS THAT MODULATE BITTER TASTE
#303Anti-DR6 antibodies and methods of immune regulation
#304Modulation of T cell signaling threshold and T cell sensitivity to antigens
#305SCREENING ASSAY FOR AGENTS THAT INFLUENCE BETA CELL NUMBER AND/OR PHENOTYPE
#306Cardiotoxicity screening methods
#307Proteasome inhibition assay and methods of use
#308Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#309E2F reporter melanoma cells
#310Method for preparing topographically structured microarrays
#311Methods for treating and/or limiting development of diabetes
#312Feline bitter taste receptors and methods
#313Pharmaceutical composition for the treatment and/or prevention of disease involving abnormal accumulation of amyloid β protein
#314In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants
#315Preventive and therapeutic drug for cartilaginous hyperplasia and method of screening for the same
#316Red genetically encoded calcium indicators and methods of use
#317SYSTEMS AND METHODS FOR ASSESSING MODULATORS OF IMMUNE CHECKPOINTS
#318Neuronal cells cultured on microparticles and methods of using same
#319Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
#320Screening methods for cognitive enhancers
#321Methods of using U2-OS cells to identify potential sweet taste modulators
#322DEVICES AND METHODS FOR SINGLE CELL ANALYSIS
#323Regulators of NFAT
#324ApoIII and the Treatment and Diagnosis of Diabetes
#325CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN
#326Promoting Apoptosis Of Differentiated Adipocytes And Increasing Endogenous Expression Of sFRP-5 Peptide By Adipocytes By Administration Of sFRP-5 Peptide
#327Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment
#328Feline bitter taste receptors and methods
#329TMEM120A ion channel modulator
#330Treatment of muscular dystrophy
#331T1R taste receptors and genes encoding same
#332Genetically encoded calcium indicators and methods of use
#333PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#334Nucleic acids encoding a cold- and menthol-sensitive receptor
#335ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS
#336Agents that modulate immune cell activation and methods of use thereof
#337Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
#338METHODS FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC TARGETING
#339Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
#340Methods and compositions for modifying sensorial perception
#341Method for identifying compounds that modulate a T2R taste receptor
#342Method for evaluating the scent performance of perfumes or perfume mixtures
#343Methods for treating and/or limiting development of diabetes
#344IDENTIFICATION OF ENZYME ACTIVITY THROUGH DETERMINATION OF ITS LOCALIZATION
#345Sperm-Specific Cation Channel, and Uses Therefor
#346Method for treating crohn'S disease or ulcerative colitis by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
#347MODULATORS OF ION TRANSPORT PROTEINS OR ION CHANNELS AND METHODS OF IDENTIFYING AND USING SAME
#348IDENTIFICATION OF FUNCTIONAL CELL STATES
#349Screening Assay for Insecticides
#350Complement split product C4d for the treatment of inflammatory conditions
#351Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology
#352Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
#353Peptide inhibitors as novel anti-HIV therapeutics
#354Methods for treatment of cardiovascular disease
#355Whole blood assay for measuring AMPK activation
#356Agent for Treating Allergic or Hypersensitivity Condition
#357αO-superfamily conotoxin peptide, pharmaceutical composition and use thereof
#358Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#359HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES
#360BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#361Human taste cells capable of continuous proliferation
#362METHOD FOR INTEGRIN LIGAND DISCOVERY
#363Theramutein modulators
#364Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity
#365Method for predicting the response to HER2-directed therapy
#366Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases
#367CD147 as receptor for pilus-mediated adhesion of to vascular endothelia
#368Methods for the Characterisation of Interaction Sites on Target Proteins
#369Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#370Method of Modifying Fertility
#371Process for making modulators of cystic fibrosis transmembrane conductance regulator
#372STEROID HORMONE AND CHOLESTEROL PATHWAYS AS ONE UNIFIED HOMEOSTATIC SYSTEM
#373EXPRESSION CONSTRUCTS ENCODING G PROTEIN COUPLED RECEPTORS AND METHODS OF USE THEREOF
#374Use of T1R3 venus flytrap region polypeptide to screen for taste modulators
#375Methods and Compositions for Treatment of Autism
#376Multiplex methods to assay mixed cell populations simultaneously
#377Identification of olfactory receptors sensitive to different odorants
#378DISEASE PATHWAY-BASED METHOD TO GENERATE BIOMARKER PANELS TAILORED TO SPECIFIC THERAPEUTICS FOR INDIVIDUALIZED TREATMENTS
#379Mutations of the GPR179 Gene in Congenital Stationary Night Blindness
#380Methods and G proteins for screening and identifying ligands of G protein-coupled receptors
#381Profiling of signal pathway proteins to determine therapeutic efficacy
#382Methods for diagnosis, prognosis and methods of treatment
#383Methods of identifying, isolating and using odorant and aroma receptors
#384Modulation of T cell signaling threshold and T cell sensitivity to antigens
#385Carbofluorescein lactone ion indicators and their applications
#386Tools and methods for expression of membrane proteins
#387Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt
#388COMPOSITIONS AND METHODS FOR SCREENING AND TREATMENT OF STURGE-WEBER SYNDROME, KLIPPEL-TRENAUNAY-WEBER SYNDROME, AND PORT-WINE STAINS (PWSS)
#389Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling
#390Channelrhodopsins for optical control of cells
#391EXPRESSION OF G-PROTEIN COUPLED RECEPTORS (GPCRs)
#392Sensors and assays for ubiquitin or ubiquitin-like proteins
#393Methods and compositions for treating or preventing pruritis
#394MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#395MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#396Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides
#397Methods for Identifying Janus Kinase (JAK) Modulators for Therapeutics
#398METHODS OF USING F-SPONDIN AS A BIOMARKER FOR CARTILAGE DEGENERATIVE CONDITIONS AND BONE DISEASES
#399Methods for Identifying and Compounds Useful for Increasing the Functional Activity and Cell Surface Expression of CF-Associated Mutant Cystic Fibrosis Transmembrance Conductance Regulator
#400PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#401Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
#402Assays for identifying compounds that modulate bitter taste
#403USE FOR GLYCOLIPOPROTEIN GINTONIN, ISOLATED AND IDENTIFIED FROM GINSENG, AS A NATURAL MEDICAL-PLANT DERIVED LIGAND
#404Compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications
#405Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt
#406Gpr177 as target and marker in tumors
#407METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LYMPHOID MALIGNANCY
#408Fibrosuppressant Biotherapeutics
#409METHODS FOR USE WITH BAFF ANTAGONISTS
#410Cell-based methods for measuring activity of a protein inhibitor
#411Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#412INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#413BENCHMARKS FOR NORMAL CELL IDENTIFICATION
#414Method for identifying compounds that modulate a T2R taste receptor
#415Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
#416TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
#417Genetically encoded calcium indicators
#418Methods and agents for modulating protocadherin-18 activity
#419G-protein coupled receptor polypeptides involved in sensory transduction
#420ANALYSIS OF NODES IN CELLULAR PATHWAYS
#421Methods for treating and/or limiting development of diabetes
#422T1R taste receptors and genes encoding same
#423NRF2 Screening Assays and Related Methods and Compositions
#424Methods for treatment of cardiovascular disease
#425Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
#426Pan-kinase activation and evaluation of signaling pathways
#427Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#428Function homology screening
#429Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#430Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
#431DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS
#432Communication and monitoring of a battery via a single wire
#433DEVICE, SYSTEM AND METHOD FOR DETECTING A SENSORY PERCEPTION
#434METHODS AND COMPOSITIONS FOR STIMULATING A FELIDAE T1R RECEPTOR
#435Methods and compositions for detecting the activation state of multiple proteins in single cells
#436Method for determination or evaluation of test substance
#437Methods To Identify Modulators
#438Process for making modulators of cystic fibrosis transmembrane conductance regulator
#439Methods for inhibiting hematopoiesis with a hedgehog antagonist
#440USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#441Method of toxicological evaluation, method of toxicological screening and associated system
#442Methods of identifying modulators of GPR17
#443METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#444BIOSENSORS COMPRISING PROTEIN-BINDING DOMAINS AND FLUORESCENT PROTEINS
#445Methods for Diagnosis, Prognosis and Methods of Treatment
#446Molecular determinants in the HIV-1 envelope associated with enhanced ability to enter CXCR4-expressing cells
#447T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#448Map kinase kinase kinase kinase 3 (MAP4K3) as a biomarker and therapeutic target for autoimmune disease, cancer, inflammation and IL-17-associated disease
#449MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF
#450Method for integrin ligand discovery
#451Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling
#452EPITOPE TESTING USING SOLUBLE HLA
#453Methods for treating and/or limiting development of diabetes
#454Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
#455METHOD OF TREATING PSYCHOLOGICAL DISORDERS
#456Methods for diagnosis, prognosis and methods of treatment
#457Methods and compositions for detecting the activation state of multiple proteins in single cells
#458Dynamic monitoring of activation of receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
#459Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer
#460Methods for treatment with bucindolol based on genetic targeting
#461PI3K MODULATORS, RHO KINASE MODULATORS AND METHODS OF IDENTIFYING AND USING SAME
#462Method for screening a potential modulator compound of a taste receptor
#463KITS FOR MULTIPARAMETRIC PHOSPHO ANALYSIS
#464METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#465T1R taste receptors and genes encoding same
#466SPLIT-LUCIFERASE C-MYC SENSOR AND USES THEREOF
#467DRUG SELECTION FOR CANCER THERAPY BY PROFILING SIGNAL TRANSDUCTION PROTEINS IN ASCITES OR PLEURAL EFFLUX SAMPLES
#468Treatment for Amyotrophic Lateral Sclerosis
#469NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE
#470METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#471Modulators of cystic fibrosis transmembrane conductance regulator
#472Monitoring gene silencing and annotating gene function in living cells
#473Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#474Treatment for multiple sclerosis
#475HEDGEHOG INHIBITOR ASSAY
#476Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
#477Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#478Whole blood assay for measuring AMPK activation
#479Detection of cells expressing T1R2 taste receptor
#480Screening methods for cognitive enhancers
#481T1R taste receptors and genes encoding same
#482PATHWAYS CHARACTERIZATION OF CELLS
#483Apparatus and Methods for Using Biological Material to Discriminate an Agent
#484Protein fragment complementation assays for high-throughput and high-content screening
#485PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION
#486Methods for identifying compounds that modulate sensory signaling through the taste cell specific G-protein coupled receptor GPCR-B4
#487G protein coupled receptor protein and use thereof
#488TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA
#489PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#490TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE
#491Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
#492Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
#493Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#494WHOLE BLOOD ASSAY OF AN INTRACELLULAR BIOMARKER OF A CELL SIGNALLING PATHWAY USE IN MEASURING THE ACTIVATION OF A PREDETERMINED CELL POPULATION
#495METHOD FOR SCREENING COMPOUNDS FOR THE TREATMENT OR PREVENTION OF COLON CANCER
#496Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation
#497METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
#498Modulators of cystic fibrosis transmembrane conductance regulator
#499METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#500DENDRITIC CELL MODULATORY MOLECULE
#501Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
#502METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS
#503METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#504METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#505Nucleic acid encoding a T2R taste receptor
#506METHODS FOR TREATMENT OF DEGENERATIVE DISEASE ASSOCIATED WITH APOPTOSIS
#507COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE
#508Homogeneous activity test for determining enzymatic reactions
#509Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#510Anti-cancer drug screening method using RORα
#511COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY
#512Antisense modulation of interleukins 17 and 23 signaling
#513Methods of identifying adipocyte specific genes, the genes identified, and their uses
#514INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#515METHODS OF IDENTIFYING MODULATORS OF THE PP2A B56 BETA REGULATORY SUBUNIT
#516Drug selection for gastric cancer therapy using antibody-based arrays
#517Methods for treatment of cardiovascular disease
#518METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#519Drug selection for lung cancer therapy using antibody-based arrays
#520Detection of Activation of Endothelial Cells as Surrogate Marker for Angiogenesis
#521Methods and Compositions for Risk Stratification
#522Regulators of NFAT
#523Methods for diagnosis, prognosis and methods of treatment
#524Screening assay for insecticides
#525In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors
#526Targeted chemical high-throughput screening method
#527METHODS AND COMPOSITIONS FOR DETECTING THE ACTIVATION STATE OF MULTIPLE PROTEINS IN SINGLE CELLS
#528BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#529Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator
#530ApoIII and the treatment and diagnosis of diabetes
#531METHODS FOR TESTING BINDING OF A LIGAND TO A G PROTEIN-COUPLED RECEPTOR
#532Host cell kinases as targets for antiviral therapies against HCV infection
#533Methods and compositions for risk stratification
#534Cell lines expressing T1R2/T1R3 hetero-oligomeric taste receptors and assay system thereof for identification of taste compounds
#535METHODS AND COMPOSITIONS FOR DETECTING RECEPTOR-LIGAND INTERACTIONS IN SINGLE CELLS
#536Methods and compositions for detecting receptor-ligand interactions in single cells
#537Methods of indentifying sweet taste modulators
#538Methods of detecting T1R2- and T1R3-expressing cells potentially sensitive to sweet tastants
#539Methods and compositions for detecting receptor-ligand interactions in single cells
#540Methods and compositions for risk stratification
#541Leptin peptide antagonists
#542Cell, method and kit for conducting an assay for neutralizing antibodies
#543Method of Identifying Agents that Promote Axonal Development
#544METHODS FOR TREATING NEOPLASTIC DISEASE TARGETING O-LINKED N-ACETYLGLUCOSAMINE MODIFICATIONS OF CELLULAR PROTEIN
#545Response Element Regions
#546SCREEN FOR INHIBITORS OF HIV REPLICATION
#547Method for predicting the response to HER2-directed therapy
#548Fibrosuppressant Biotherapeutics
#549NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS
#550Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
#551Compositions and methods affecting the signaling pathways of LRP receptors
#552Methods for diagnosis, prognosis and methods of treatment
#553PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION
#554Composition for treating virus infection disease comprising Jab1
#555Methods for regulation of stem cells
#556SYSTEMS AND METHODS FOR IDENTIFICATION OF CILIOPATHY THERAPEUTICS
#557EPITOPE TESTING USING SOLUBLE HLA
#558Methods for identifying compounds for the treatment of type 1 diabetes
#559ANALYSIS OF CELL NETWORKS
#560Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof
#561Method of promoting apoptosis of differentiated adipocytes and increasing endogenous expression of SFRP-5 peptide by administration of SFRP-5 peptide
#562Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
#563Modulation of T cell signaling threshold and T cell sensitivity to antigens
#564Expansion Of Renewable Stem Cell Populations
#565Methods of suppressing microglial activation
#566Methods and compositions for detecting the activation state of multiple proteins in single cells
#567Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
#568Histidine related compounds for identifying and blocking amyloid beta ion channels
#569Neuronal cells cultured on microparticles and methods of using the neuronal cells
#570Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma
#571Methods of screening for a compound that reduces atherogenesis
#572Method for identifying compounds for treatment of pain
#573Methods for use with BAFF antagonists
#574Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#575Multiplex cell signalling assays
#576METHODS AND SYSTEMS FOR PREDICTING PROTEIN-LIGAND COUPLING SPECIFICITIES
#577Toll-Like Receptor 9 Modulators
#578Leukemic cell CNS infiltration controlled by notch-induced chemotaxis
#579Methods of screening and compositions for life span modulators
#580CD36 MODULATION AND USES THEREOF
#581METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN
#582Process for making modulators of cystic fibrosis transmembrane conductance regulator
#583Kits for multiparametric phospho analysis
#584MODULATORS OF ODORANT RECEPTORS
#585Methods and compositions for risk stratification
#586ANALYSIS OF NODES IN CELLULAR PATHWAYS
#587MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#588Method of treating glaucoma comprising administering a composition comprising human BMP7
#589Method for using division arrested cells in screening assays
#590Methods and Compositions for Detecting Receptor-Ligand Interactions in Single Cells
#591Compounds for enhancing p21 expression and methods of use thereof
#592REDUCING POLYGLUTAMINE-BASED AGGREGATION
#593METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
#594METHODS OF CREATING AN INDEX
#595METHODS FOR CHARACTERIZING MOLECULES
#596Modulators of cystic fibrosis transmembrane conductance regulator
#597Evaluating RTK Target Drugs
#598METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#599Combinations of ET-18-O-CHand anti-cancer agents for the treatment of cancer
#600Methods for Analyzing Drug Response